Guillot, PV;
(2016)
Induced pluripotent stem (iPS) cells from human fetal stem cells.
Best Practice & Research Clinical Obstetrics & Gynaecology
, 31
pp. 112-120.
10.1016/j.bpobgyn.2015.08.007.
Preview |
Text
Guillot_YBEOG GUILLOT (002).pdf - Accepted Version Download (292kB) | Preview |
Abstract
Pluripotency defines the ability of stem cells to differentiate into all the lineages of the three germ layers and self-renew indefinitely. Somatic cells can regain the developmental potential of embryonic stem cells following ectopic expression of a set of transcription factors or, in certain circumstances, via modulation of culture conditions and supplementation with small molecule, that is, induced pluripotent stem (iPS) cells. Here, we discuss the use of fetal tissues for reprogramming, focusing in particular on stem cells derived from human amniotic fluid, and the development of chemical reprogramming. We next address the advantages and disadvantages of deriving pluripotent cells from fetal tissues and the potential clinical applications.
| Type: | Article |
|---|---|
| Title: | Induced pluripotent stem (iPS) cells from human fetal stem cells |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.bpobgyn.2015.08.007 |
| Publisher version: | http://dx.doi.org/10.1016/j.bpobgyn.2015.08.007 |
| Language: | English |
| Additional information: | © 2015 Elsevier Ltd. All rights reserved.This manuscript version is made available under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International license (CC BY-NC-ND 4.0). This license allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licenses are available at https://creativecommons.org/licenses/. Access may be initially restricted by the publisher. |
| Keywords: | Reprogramming, small molecules, fetal stem cells, induced pluripotency, transcription factors, translational medicine, Mesenchymal Stromal Cells, Small-molecule Compounds, OCT4 Promoter Activity, Valproic Acid, Somatic-cells, Osteogenesis Imperfecta, Human Fibroblasts, Nuclear Transfer, Defined Factors, High-efficiency |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Maternal and Fetal Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1484053 |
Archive Staff Only
 |
View Item |
